Article 01 Sep 2023 In Re Cellect: Federal Circuit Opens New Path For Double Patenting Challenges United States IP
Article 07 Sep 2022 PTAB Institutes IPRs Of Tocilzumab Patents Challenged By Celltrion United States IP